Société Puma Biotechnology Inc OTC Bulletin Board
Actions
PBYI
US74587V1070
Recherche biotechnologique et médicale
Métier
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Cancer Care Products
100,0
%
| 228 | 100,0 % | 236 | 100,0 % | +3,34% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 228 | 100,0 % | 236 | 100,0 % | +3,34% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15/09/10 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 05/11/18 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/03/13 |
Investor Relations Contact | - | - | |
Jeffrey Ludwig
PRN | Corporate Officer/Principal | 58 | 01/03/20 |
Douglas Hunt
LAW | General Counsel | 59 | 01/01/18 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 23/02/18 |
Jay Moyes
BRD | Director/Board Member | 70 | 27/04/12 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15/09/10 |
Director/Board Member | 63 | 29/07/22 | |
Director/Board Member | 60 | 11/08/15 | |
Troy Wilson
BRD | Director/Board Member | 55 | 18/10/13 |
Allison Dorval
BRD | Director/Board Member | 48 | 15/07/21 |
Brian Stuglik
BRD | Director/Board Member | 64 | 05/07/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 48 238 850 | 40 808 140 ( 84,60 %) | 0 | 84,60 % |
Coordonnées société
Puma Biotechnology, Inc.
10880 Wilshire Boulevard Suite 2150
90024-4101, Los Angeles
+
http://www.pumabiotechnology.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+43,36% | 54,63 Md | |
-5,31% | 39,92 Md | |
+37,52% | 38,82 Md | |
+14,75% | 26,86 Md | |
-12,56% | 26,22 Md | |
-22,45% | 18,78 Md | |
+25,12% | 12,21 Md | |
+0,04% | 12,16 Md | |
+26,04% | 11,94 Md |